Clinical Trial Update: A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis [Phase 1]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1 study evaluating the combination of oral vismodegib with pirfenidone in participants with idiopathic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Erivedge (vismodegib)
• Esbriet (pirfenidone)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED